Average Co-Inventor Count = 8.10
ph-index = 4
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Cancer Research Technology Limited (9 from 265 patents)
2. The Institute of Cancer Research (1 from 24 patents)
3. The Institute of Cancer Research: Royal Cancer Hospital (52 patents)
9 patents:
1. 12110286 - Benzimidazolone derived inhibitors of BCL6
2. 11897877 - Inhibitor compounds
3. 11046688 - Inhibitor compounds
4. 10479788 - Compounds that inhibit MPS1 kinase
5. 10399974 - N2-phenyl-pyrido[3,4-D]pyrimidine-2, 8-diamine derivatives and their use as Mps1 inhibitors
6. 9902721 - N2-phenyl-pyrido[3,4-d]pyrimidine-2, 8-diamine derivatives and their use as Mps1 inhibitors
7. 9890157 - Inhibitor compounds
8. 9834552 - Inhibitor compounds
9. 9409907 - Inhibitor compounds